News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers
Pierre Blanchard/X
May 4, 2025, 12:45

Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers

Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, shared a post on X:

“SBRT (6*6Gy) is a new treatment option for small oral cavity cancers (T1-2) at risk of local recurrence after resection (R1, PNI..): Julian Biau reports the STEREOPOSTOP GORTEC 2017-03.

  • Convenient.
  • Fast.
  • Similar outcomes than post op brachy.

Mostly VMAT homogeneous plans.”

Pierre Blanchard highlighted findings from the STEREOPOSTOP GORTEC 2017-03 study, reporting SBRT as a viable post-resection treatment for small oral cavity cancers.

The approach offers convenience, speed, and comparable outcomes to postoperative brachytherapy, with predominantly homogeneous VMAT plans.

Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers

More posts featuring Pierre Blanchard.

cancer fight against cancer Global fight against cancer Gustave Roussy Cancer Institute Julian Biau OncoDaily Oncology oral cavity cancers Pierre Blanchard radiation oncology SBRT STEREOPOSTOP GORTEC VMAT homogeneous plans
Special Coverage
Blog
May 4, 2025, 12:45
Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers
Blog
May 4, 2025, 12:41
Francesco Massari highlights ARON Project at Brown University’s GU translational research meeting
Blog
May 4, 2025, 12:33
Giulio Francolini: QoL data from DART trial
Science
May 4, 2025, 12:21
Breast Cancer in Young patients at ESTRO 2025: The Impact of BRCA-carriership on indications for RT
Science
May 4, 2025, 11:47
Breast Cancer in Young patients at ESTRO 2025: Reproductive issues in young BRCA carriers affected by breast cancer
Insight
May 4, 2025, 11:45
Sergio Cifuentes highlights key limitations of the PLATFORM study on esophagogastric adenocarcinoma
Insight
May 4, 2025, 11:29
STELLAR II trial at ESTRO 2025: Immunotherapy Combined with Radiotherapy and Chemotherapy Reduces the Need for Surgery in Locally Advanced Rectal Cancer
Blog
May 4, 2025, 11:26
Collaboration between National Societies and Patients can Strengthen Advocacy - ESTRO
Blog
May 4, 2025, 11:14
Marie-Catherine Vozenin Honored with Claudius Regaud Award at ESTRO 2025
Blog
May 4, 2025, 11:13
Princess Dina Mired: A true trailblazer in Pediatric Oncology by Carlos Rodriguez-Galindo
Blog
May 4, 2025, 11:11
Ina Jürgenliemk-Schulz Receives Iridium 192 Award at ESTRO 2025
Societies
May 4, 2025, 11:03
ASCO Urges Lawmakers to Protect Federal Funding for Cancer Research and Prevention